Hydroxyurea and periodicity in myeloproliferative disease.

Bennett, M

Hydroxyurea and periodicity in myeloproliferative disease. [electronic resource] - European journal of haematology May 2001 - 317-23 p. digital

Publication Type: Case Reports; Journal Article

0902-4441

10.1034/j.1600-0609.2001.066005317.x doi


Adult
Aged
Antineoplastic Agents--adverse effects
Blood Cell Count
Busulfan--therapeutic use
Female
Hemoglobins--analysis
Humans
Hydroxyurea--adverse effects
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--blood
Leukocyte Count
Lymphocytes
Male
Monocytes
Neutrophils
Periodicity
Platelet Count
Polycythemia Vera--blood
Quinazolines--therapeutic use